Researchers Determine Best Metrics for Predicting Survival in Ewing Sarcoma
FDG-PET testing that shows early progression of patients with Ewing sarcoma is linked to reduced overall survival.
All articles by John Eckman
Sentinel Lymph Node Biopsy Recommended for Patients With Sarcoma
SLNB are more reliable PET-CT for assessing lymph node metastases among young patients with sarcoma.
Compliance With NCCN Guidelines Benefits Patients With Rectal Cancer
Adjuvant chemotherapy is beneficial for patients with locally-advanced, postoperative rectal cancer.
Degree of Nodal Involvement has Prognostic Significance for NSCLC
Lymph node staging has prognostic significance for patients with non-small-cell lung cancer (NSCLC) that has metastasized to the chest (M1a).
Positive Optimization of Patient Expectations Before Treatment Recommended
A patient’s expectations may influence his or her adherence to medication regimens, quality of life, and reported side effects.
Baseline Metabolic Tumor Volume Predicts Prognosis of Follicular Lymphoma
Total metabolic tumor volume is effective for determining the prognosis of high-tumor-burden follicular lymphoma.
Polycystic Kidney Disease Correlated With Risk of Cancer
Polycystic kidney disease (PKD) may increase one’s risk of developing cancer of the liver, colon, and kidney.
Cancer Overtakes CVD as Leading Cause of Death Among Men in Western European Countries
Cancer appears to be overtaking cardiovascular disease (CVD) as the leading cause of mortality in many European countries.
Dasatinib and Nilotinib Similarly Efficacious for CML in Chronic Phase
Dasatinib and nilotinib show no significant difference in treatment efficacy for treatment-naive patients with chronic myeloid leukemia in chronic phase (CML-CP).
BTK Inhibitors May Be Linked to Pneumocystis jirovecii Pneumonia
Patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib may have a mildly elevated risk of developing Pneumocystis jirovecii pneumonia (PCP).
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...